<SEC-DOCUMENT>0001528287-22-000004.txt : 20220310
<SEC-HEADER>0001528287-22-000004.hdr.sgml : 20220310
<ACCEPTANCE-DATETIME>20220310160648
ACCESSION NUMBER:		0001528287-22-000004
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220310
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220310
DATE AS OF CHANGE:		20220310

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroPace Inc
		CENTRAL INDEX KEY:			0001528287
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				223550230
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40337
		FILM NUMBER:		22729099

	BUSINESS ADDRESS:	
		STREET 1:		455 N. BERNARDO AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6502372700

	MAIL ADDRESS:	
		STREET 1:		455 N. BERNARDO AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>npce-20220310.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:bc235835-481b-41f5-8755-4f29962795e7,g:ef443e73-be52-4b98-b40c-a81f6b610a72,d:fe68f704258a4b77b69ff0e7f08d66a9--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>npce-20220310</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV80L2ZyYWc6MTk4ODI0NmUwZTM2NGU1ZmFmODgzYWE3NGE2Nzk4OTMvdGFibGU6MjIxNGY0YjI5ZWY5NDkxMGE1ZTkxZWNiNGIyNGViYmMvdGFibGVyYW5nZToyMjE0ZjRiMjllZjk0OTEwYTVlOTFlY2I0YjI0ZWJiY18wLTEtMS0xLTQ3NTkz_9dc57f9f-7d2d-4533-af1a-f231d9fbe8f5">0001528287</ix:nonNumeric><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV80L2ZyYWc6MTk4ODI0NmUwZTM2NGU1ZmFmODgzYWE3NGE2Nzk4OTMvdGFibGU6MjIxNGY0YjI5ZWY5NDkxMGE1ZTkxZWNiNGIyNGViYmMvdGFibGVyYW5nZToyMjE0ZjRiMjllZjk0OTEwYTVlOTFlY2I0YjI0ZWJiY18xLTEtMS0xLTQ3NTkz_33903cdd-7c0f-4e10-80af-2b6c1cc95f7c">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="npce-20220310.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001528287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-10</xbrli:startDate><xbrli:endDate>2022-03-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ife68f704258a4b77b69ff0e7f08d66a9_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQw_85aa7daa-aa97-4674-a1b6-badd0db369b6">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yMjM_68fae99c-d1b5-4c14-9130-3ba185da4f50">March 10, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:26pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjM2_db5cb116-fdf6-461f-a408-00fb40abe817">NEUROPACE, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8wLTAtMS0xLTQ3NTkzL3RleHRyZWdpb246NzczOThkZWM4Y2Q2NDJiY2E4OGU0NGI3OTUwYjFlMWZfMjg_5eafaf40-7819-45f7-acc0-f6af0fb7e773">Delaware</ix:nonNumeric></span></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or Other Jurisdiction</span></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8wLTEtMS0xLTQ3NTkzL3RleHRyZWdpb246NTkyMzY3OTAzMzhjNGEzMjgwMTY5NjFhNDg4NjYyMDRfMjg_77e3230a-5c58-4539-8dce-9fd942ea7e20">001-40337</ix:nonNumeric></span></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Commission File Number) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8wLTItMS0xLTQ3NTkzL3RleHRyZWdpb246YjQ3ODdmZGFjN2IwNGE5Y2IzODY1MWU0ZGFkYThhMTdfMjc_b04822b6-4c0f-4704-bbab-c9c95f13bf67">22-3550230</ix:nonNumeric></span></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(IRS Employer</span></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8xLTAtMS0xLTQ3NTkzL3RleHRyZWdpb246NWQ2OGNlNjk2ZDJhNDc1ZTk1ZWVhM2M0ZTNhZmMzYTBfMTQ_2b853139-57bd-4eda-b29a-ff021118b066">455 N. Bernardo Avenue</ix:nonNumeric></span></div><div style="padding-left:2.75pt;padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8xLTAtMS0xLTQ3NTkzL3RleHRyZWdpb246NWQ2OGNlNjk2ZDJhNDc1ZTk1ZWVhM2M0ZTNhZmMzYTBfMjg_11faa71c-7ffe-4059-a671-fddba93a94e4">Mountain View</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8xLTAtMS0xLTQ3NTkzL3RleHRyZWdpb246NWQ2OGNlNjk2ZDJhNDc1ZTk1ZWVhM2M0ZTNhZmMzYTBfMzI_403803c2-454e-486c-92ca-b1d63f802ce9">CA</ix:nonNumeric></span></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8xLTItMS0xLTQ3NTkzL3RleHRyZWdpb246YmU4NDVkY2M4MDdmNDE2ZmFkM2U5YmMzNDUxZjFmZGNfMzI_b4032e62-5acc-462a-bba6-3079007a637f">94043</ix:nonNumeric></span></div><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Zip Code)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjM3_41a9ecbf-b16b-4845-8b18-7b5e20865bd0">650</ix:nonNumeric>) <ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQx_a10271df-dfd5-4f29-b177-4596c6312788">237-2700</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Not Applicable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> General Instructions A.2. below):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:-0.6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQy_75dd2df6-9ed6-4eb0-95b0-67123ca39ff5">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:-0.6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjM4_ac205e1e-850c-4c0c-b13d-c60c9aba7c3a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:-0.6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQ0_6d35cf58-ea0a-4129-b82b-e34f787e4cb6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:-0.6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjM5_a2bc9d3e-5430-4cee-9fce-b4d6432d9478">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6M2E0YTFhNDI5YmRmNGFlZWEzNjQxZTZkNGRiN2JkYzEvdGFibGVyYW5nZTozYTRhMWE0MjliZGY0YWVlYTM2NDFlNmQ0ZGI3YmRjMV8xLTAtMS0xLTQ3NTkz_105ae8ea-c440-4d45-9fce-b2e2f845f5ba">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6M2E0YTFhNDI5YmRmNGFlZWEzNjQxZTZkNGRiN2JkYzEvdGFibGVyYW5nZTozYTRhMWE0MjliZGY0YWVlYTM2NDFlNmQ0ZGI3YmRjMV8xLTItMS0xLTQ3NTkz_7fa3bf73-4c6b-47ae-be94-0cc578ac4fb3">NPCE</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6M2E0YTFhNDI5YmRmNGFlZWEzNjQxZTZkNGRiN2JkYzEvdGFibGVyYW5nZTozYTRhMWE0MjliZGY0YWVlYTM2NDFlNmQ0ZGI3YmRjMV8xLTQtMS0xLTQ3NTkz_382455e2-77a1-4cb7-a7be-73c0ff72cbfd">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQ1_6bea7afb-bea0-402d-a9b8-5898673b066e">&#9746;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQ2_4f1543e9-2968-484e-bd47-13fa2776ab55">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 2.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="padding-right:11pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On March 10, 2022, NeuroPace, Inc. issued a press release announcing its financial results for the fiscal quarter and full year ended December 31, 2021. A copy of the press release dated March 10, 2022, is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="padding-right:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing information (including the exhibit hereto) is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div style="padding-left:32pt;text-indent:-31.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="padding-left:32pt;text-indent:-31.6pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.528%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit991_q42021earningsr.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Press release dated March 10, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="padding-left:32pt;text-indent:-31.6pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NeuroPace, Inc.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dated: March 10, 2022</span></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">/s/ Rebecca Kuhn</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rebecca Kuhn</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Financial Officer and Vice President, Finance and Administration</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991_q42021earningsr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i93db6848f7ce4f74aa8f71e7df4d7ff1_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><img alt="nps_logoxweb-rgb.gif" src="nps_logoxweb-rgb.gif" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:258px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:107%">NeuroPace Reports Fourth Quarter &#38; Full Year 2021 Financial Results</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Mountain View, Calif.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#8211;March 10, 2022 &#8211; NeuroPace, Inc. (Nasdaq&#58; NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported financial results for the fourth quarter and full year ended December 31, 2021.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Recent Highlights</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Total revenue of $45.2 million for 2021, representing a 10% increase over 2020</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Initial implant revenue of $33.7 million for 2021, representing a 20% increase over 2020</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Replacement implant revenue of $11.5 million for 2021, representing a 12% decrease over 2020 </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">150 level 4 comprehensive epilepsy centers completed an RNS System implant in 2021, representing a 14% increase over 2020</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Total revenue of $11.0 million for the fourth quarter of 2021, representing a 2% increase over the prior year period in 2020</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Initial implant revenue of $8.5 million for the fourth quarter of 2021, representing a 10% increase over the prior year period</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Replacement implant revenue of $2.5 million for the fourth quarter of 2021, representing a 19% decrease over the prior year period</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Received FDA approval of the IDE for a pivotal study in patients with drug resistant primary generalized epilepsy</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Received FDA approval to increase average battery life claim for the RNS System to nearly 11 years under typical use conditions</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Issued full year 2022 revenue guidance range of $45 million to $48 million</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;I am proud of our team&#8217;s execution in 2021, as we expanded the number implanting centers to 150 and delivered 20% initial implant revenue growth for the full year,&#8221; said Mike Favet, Chief Executive Officer of NeuroPace. &#8220;In 2021, we also enrolled our first patient in the adolescent study and received IDE approval for primary generalized epilepsy &#8211; both important steps to expand our indication and market opportunity. As we look beyond the temporary headwinds associated with the COVID-19 pandemic, in 2022 we plan to accelerate sales force hiring and invest in programs designed to target patients and referring physicians to improve EMU patient volumes and drive long-term sustainable growth.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Fourth Quarter 2021 Financial Results</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Total revenue was $11.0 million in the fourth quarter of 2021, a 2% increase from $10.8 million in the prior year period. Initial implant revenue was $8.5 million, a 10% increase from $7.7 million in the prior year period. Replacement implant revenue was $2.5 million, a 19% decrease compared to the prior year period. This reduction in replacement implant revenue was expected. Replacement implant revenue will continue to generally decrease until a significant number of devices with the longer lasting battery reach end of service. More than 90% of patients have had their NeuroPace device replaced when the battery reaches end of service, so replacement implant revenue is primarily a function of when the batteries in the previously implanted devices reach end of service. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Gross margin for the fourth quarter of 2021 was 73% compared to 76% in the fourth quarter of 2020. The decline in gross margin relative to the prior year period was primarily due to an increase in certain costs as manufacturing operations returned to normal levels following COVID-related disruptions in 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Total operating expenses in the fourth quarter of 2021 were $17.1 million, compared with $11.2 million in the prior year period. R&#38;D expense in the fourth quarter was $5.3 million compared with $3.9 million in the prior </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">year period. The increase in R&#38;D expense was primarily driven by an increase in product development and clinical study expenses. SG&#38;A expense in the fourth quarter of 2021 was $11.7 million compared with $7.3 million in the prior year period. The increase in SG&#38;A expense was primarily driven by increased costs associated with operating as a public company and increased sales and marketing expenses. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Net loss was $10.7 million for the fourth quarter of 2021, compared to a net loss of $4.6 million in the prior year period. Interest expense in the fourth quarter of 2021 was $1.9 million, flat compared to the prior year period. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Cash, cash equivalents and marketable securities were $115.6 million and long-term borrowings were $49.8 million as of December 31, 2021.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2022 Financial Guidance</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Management continues to take a measured approach given the uncertainty surrounding COVID-19, including the risk posed by new variants and the potential impact on hospital, physician and patient behavior&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">First Quarter 2022 Guidance</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Total revenue of $10 million to $11 million</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Initial implant revenue of $8 million to $8.5 million</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Replacement implant revenue of $2 million to 2.5 million</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Full Year 2022 Guidance</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Total revenue of $45 million to $48 million</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Initial implant revenue of $39 million to $42 million</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Active implanting centers to increase approximately 10% compared to 2021</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Replacement implant revenue of approximately $6 million</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Gross margin in the mid-70% range</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Total operating expenses of $74 million to $76 million, which includes approximately $8 million to $9 million of non-cash stock-based compensation expense</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Webcast and Conference Call Information</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">NeuroPace will host a conference call to discuss the fourth quarter and full year 2021 financial results after market close on Wednesday, March 10, 2022, at 4&#58;30 P.M. Eastern Time. Investors interested in listening to the conference call may do so by dialing (844) 955-2173 for domestic callers or (914) 987-7949 for international callers, using conference ID&#58; 1056178. Live audio of the webcast will be available on the &#8220;Investors&#8221; section of the company&#8217;s website at&#58; https&#58;&#47;&#47;investors.neuropace.com&#47;. The webcast will be archived and available for replay for at least 90 days after the event.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">About NeuroPace, Inc. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Forward Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In addition to background and historical information, this press release contains &#8220;forward-looking statements&#8221; based on NeuroPace&#8217;s current expectations, forecasts and beliefs, including NeuroPace&#8217;s plans to accelerate </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">sales force hiring and invest in programs, and the statements under the caption &#8220;2022 Financial Guidance&#8221; above. These forward-looking statements are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Actual outcomes and results could differ materially due to a number of factors, including the ongoing uncertainty of the impact of the COVID-19 pandemic, as well as COVID recovery impact, on its business. These and other risks and uncertainties include those described more fully in the section titled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation&#8221; and elsewhere in its public filings with the U.S. Securities and Exchange Commission (SEC), including its quarterly report on Form 10-Q filed on November 10, 2021, the Annual Report on Form 10-K for the year ended December 31, 2021 to be filed with the SEC, as well as any reports that it may file with the SEC in the future. Forward-looking statements contained in this announcement are based on information available to NeuroPace as of the date hereof.  NeuroPace undertakes no obligation to update such information except as required under applicable law. These forward-looking statements should not be relied upon as representing NeuroPace&#8217;s views as of any date subsequent to the date of this press release and should not be relied upon as prediction of future events. In light of the foregoing, investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of NeuroPace.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Gilmartin Group</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Matt Bacso, CFA</font></div><div><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">investors&#64;neuropace.com</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div id="i93db6848f7ce4f74aa8f71e7df4d7ff1_4"></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:125%">NeuroPace, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Condensed Statements of Operations</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">(unaudited)</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.921%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%">(in thousands, except share and per share amounts)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Revenue</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,997&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,752&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">45,183&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,138&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cost of goods sold</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,921</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,533</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11,748</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,866</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gross profit</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,076</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,219</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">33,435</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30,272</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Operating expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and development</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,345</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,919</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">18,211</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,695</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Selling, general and administrative</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11,746</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,281</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">38,961</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">27,628</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total operating expenses</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">17,091</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11,200</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">57,172</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">43,323</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss from operations</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(9,015)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,981)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(23,737)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(13,051)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest income</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">186</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">21</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">448</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest expense </font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,862)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,883)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(7,410)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(11,486)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other income (expense), net</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">225</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(5,381)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">218</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(10,693)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(4,618)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(36,080)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,278)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss per share attributable to common stockholders, basic and diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.44)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(22.09)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2.17)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(117.85)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,166,507&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">209,092&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,608,800&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">204,068&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i93db6848f7ce4f74aa8f71e7df4d7ff1_7"></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:125%">NeuroPace, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Condensed Balance Sheets</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">(unaudited)</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.416%"><tr><td style="width:1.0%"></td><td style="width:71.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%">(in thousands, except share and per share amounts)</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2021</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">19,187&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">26,390&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Short-term investments</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">96,397</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11,689</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accounts receivable</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,091</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,395</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Inventory</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,822</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,909</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,319</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,179</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">132,816</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">54,562</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Property and equipment, net</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">603</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">515</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Restricted cash</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">122&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">366</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deferred offering costs</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">484</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">21</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">23</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">133,562&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">55,950&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Liabilities and Stockholders&#8217; Equity (Deficit)</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accounts payable</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,378&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">949&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,923</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,603</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Short-term debt</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,043&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total current liabilities</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9,301</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9,595</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deferred rent, noncurrent</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">911</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,301</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Long-term debt</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">49,847</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">50,821</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Redeemable convertible preferred stock warrant liability</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">369</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">274</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">60,059</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">62,360</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:18pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Redeemable convertible preferred stock, $0.001 par value</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">141,422</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stockholders&#8217; equity (deficit)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:18pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;Common stock, $0.001 par value</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">497,522</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">239,826</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated other comprehensive income</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(272)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">33</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated deficit</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(423,771)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(387,691)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total stockholders&#8217; equity (deficit)</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">73,503</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(147,832)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities, redeemable convertible preferred stock and stockholders&#8217; equity (deficit)</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">133,562&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">55,950&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>npce-20220310.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bc235835-481b-41f5-8755-4f29962795e7,g:ef443e73-be52-4b98-b40c-a81f6b610a72-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:npce="http://neuropace.com/20220310" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://neuropace.com/20220310">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="npce-20220310_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="npce-20220310_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://neuropace.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>npce-20220310_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bc235835-481b-41f5-8755-4f29962795e7,g:ef443e73-be52-4b98-b40c-a81f6b610a72-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_4f3825f9-f137-4902-96be-10f3a7dc6304_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_29c370fd-2451-4d7d-9c2e-ebc9fd3d6fca_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9d262e27-0e72-4536-a049-f706b8d1326b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_ba9c6131-c672-438c-a4b6-af3ad55cc3e6_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ddc7bb86-46f8-466c-b897-6667f26454e9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8d6b9906-5505-4844-ac8b-822f5cf18649_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_88fddfc9-6751-40ab-b06b-39b74ad18e3b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_349aea0e-e1f8-4af9-b2ce-252fed3a0d0e_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_b11ad81b-2f9b-46ae-b2aa-7185ebd981e0_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_bbcb533f-db75-43f5-a6ab-3f7d2a2f9d26_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a417f324-3ef1-4eb3-ad93-47fd56cb393c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b15e675a-7d65-4229-a166-9afd9593ea5e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_343a1d89-f7ac-4d38-8dbe-c7d5a4b4f86a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f4ec3ca2-fe8b-4b08-bd56-47ea2b8b2205_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1fef2ff6-af45-46b0-9888-49be9fa5cb68_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_31dbf826-396b-4629-b4e0-2d5dd55faea9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5f940d06-0c89-4e30-8941-bac7c4e323cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9ffc04e3-f88b-4434-adf1-15f6e71f0264_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b11e1d01-5f52-4a8a-916e-1bb8cb3bc151_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c34774de-f37e-4b38-b0c0-4f9317640565_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_26379047-2617-4847-8f2f-8ce2c656969b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_35e011bb-9fca-4afa-be9f-838bafba6aad_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_51cd24df-bc5b-4944-bd65-cb624d6ab496_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>npce-20220310_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bc235835-481b-41f5-8755-4f29962795e7,g:ef443e73-be52-4b98-b40c-a81f6b610a72-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://neuropace.com/role/Cover" xlink:type="simple" xlink:href="npce-20220310.xsd#Cover"/>
  <link:presentationLink xlink:role="http://neuropace.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e899ebf5-e5fc-4d48-abd2-fefaf5cca3e6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_DocumentType_e899ebf5-e5fc-4d48-abd2-fefaf5cca3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a6805d6f-d0e8-45b6-b6f7-5ec100144217" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_DocumentPeriodEndDate_a6805d6f-d0e8-45b6-b6f7-5ec100144217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cd20355e-9df2-4212-92fa-9e713b69bc6c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityRegistrantName_cd20355e-9df2-4212-92fa-9e713b69bc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2a5d3d78-c651-415d-ba8e-d9cf2cecab83" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2a5d3d78-c651-415d-ba8e-d9cf2cecab83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_87db4417-fc13-41dd-806a-55d23eeecc1b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityFileNumber_87db4417-fc13-41dd-806a-55d23eeecc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0de85242-f805-46c0-8fc8-e41b2f224458" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityTaxIdentificationNumber_0de85242-f805-46c0-8fc8-e41b2f224458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_664b1dc9-39e2-4289-bde9-039c484da1a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityAddressAddressLine1_664b1dc9-39e2-4289-bde9-039c484da1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1a0129f5-f715-4792-9fce-24d321785ae8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityAddressCityOrTown_1a0129f5-f715-4792-9fce-24d321785ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f6484dbb-e2bd-416e-9b78-abff9a20b246" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityAddressStateOrProvince_f6484dbb-e2bd-416e-9b78-abff9a20b246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b022706e-6bfb-455e-8282-9f93961c13c2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityAddressPostalZipCode_b022706e-6bfb-455e-8282-9f93961c13c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c7c527d7-6178-4451-a2e0-d8e1d5e3b4b9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_CityAreaCode_c7c527d7-6178-4451-a2e0-d8e1d5e3b4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b27c076e-25da-408f-8aff-4ddfb3a8d7d6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_LocalPhoneNumber_b27c076e-25da-408f-8aff-4ddfb3a8d7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d2c3728b-f710-42bd-ba29-27b221006dd3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_WrittenCommunications_d2c3728b-f710-42bd-ba29-27b221006dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a32363a8-833e-47fd-951e-670f904aa3c5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_SolicitingMaterial_a32363a8-833e-47fd-951e-670f904aa3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_73371454-0ffa-449c-8dad-9299f91a8487" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_PreCommencementTenderOffer_73371454-0ffa-449c-8dad-9299f91a8487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_b270ebd5-ed78-4156-9966-dfef2360669e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_b270ebd5-ed78-4156-9966-dfef2360669e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4b78f49a-e793-4eef-b6e5-31732a6ba1e5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_Security12bTitle_4b78f49a-e793-4eef-b6e5-31732a6ba1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_24f65862-c998-46da-af8a-0984e9e0f671" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_TradingSymbol_24f65862-c998-46da-af8a-0984e9e0f671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6375a84f-625f-4894-a914-1694dfc15566" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_SecurityExchangeName_6375a84f-625f-4894-a914-1694dfc15566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_29f7110d-a3e5-4b50-948f-2d5ba7bf9439" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityEmergingGrowthCompany_29f7110d-a3e5-4b50-948f-2d5ba7bf9439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_c14c36f3-d4d7-4d44-969e-45e32929eeca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityExTransitionPeriod_c14c36f3-d4d7-4d44-969e-45e32929eeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_722e76fa-29f1-4c16-984e-de12655c9052" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_EntityCentralIndexKey_722e76fa-29f1-4c16-984e-de12655c9052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_71dff738-3826-4a06-ad32-d456aa497228" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3c350130-6423-45a5-bcc2-07334460c443" xlink:to="loc_dei_AmendmentFlag_71dff738-3826-4a06-ad32-d456aa497228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>nps_logoxweb-rgb.gif
<TEXT>
begin 644 nps_logoxweb-rgb.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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2[N[^[O >[_(^[_1>[V@2$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140228454654568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 10,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEUROPACE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-3550230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">455 N. Bernardo Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mountain View<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">237-2700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NPCE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001528287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>npce-20220310_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="npce-20220310.xsd" xlink:type="simple"/>
    <context id="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001528287</identifier>
        </entity>
        <period>
            <startDate>2022-03-10</startDate>
            <endDate>2022-03-10</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV80L2ZyYWc6MTk4ODI0NmUwZTM2NGU1ZmFmODgzYWE3NGE2Nzk4OTMvdGFibGU6MjIxNGY0YjI5ZWY5NDkxMGE1ZTkxZWNiNGIyNGViYmMvdGFibGVyYW5nZToyMjE0ZjRiMjllZjk0OTEwYTVlOTFlY2I0YjI0ZWJiY18wLTEtMS0xLTQ3NTkz_9dc57f9f-7d2d-4533-af1a-f231d9fbe8f5">0001528287</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV80L2ZyYWc6MTk4ODI0NmUwZTM2NGU1ZmFmODgzYWE3NGE2Nzk4OTMvdGFibGU6MjIxNGY0YjI5ZWY5NDkxMGE1ZTkxZWNiNGIyNGViYmMvdGFibGVyYW5nZToyMjE0ZjRiMjllZjk0OTEwYTVlOTFlY2I0YjI0ZWJiY18xLTEtMS0xLTQ3NTkz_33903cdd-7c0f-4e10-80af-2b6c1cc95f7c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQw_85aa7daa-aa97-4674-a1b6-badd0db369b6">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yMjM_68fae99c-d1b5-4c14-9130-3ba185da4f50">2022-03-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjM2_db5cb116-fdf6-461f-a408-00fb40abe817">NEUROPACE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8wLTAtMS0xLTQ3NTkzL3RleHRyZWdpb246NzczOThkZWM4Y2Q2NDJiY2E4OGU0NGI3OTUwYjFlMWZfMjg_5eafaf40-7819-45f7-acc0-f6af0fb7e773">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8wLTEtMS0xLTQ3NTkzL3RleHRyZWdpb246NTkyMzY3OTAzMzhjNGEzMjgwMTY5NjFhNDg4NjYyMDRfMjg_77e3230a-5c58-4539-8dce-9fd942ea7e20">001-40337</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8wLTItMS0xLTQ3NTkzL3RleHRyZWdpb246YjQ3ODdmZGFjN2IwNGE5Y2IzODY1MWU0ZGFkYThhMTdfMjc_b04822b6-4c0f-4704-bbab-c9c95f13bf67">22-3550230</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8xLTAtMS0xLTQ3NTkzL3RleHRyZWdpb246NWQ2OGNlNjk2ZDJhNDc1ZTk1ZWVhM2M0ZTNhZmMzYTBfMTQ_2b853139-57bd-4eda-b29a-ff021118b066">455 N. Bernardo Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8xLTAtMS0xLTQ3NTkzL3RleHRyZWdpb246NWQ2OGNlNjk2ZDJhNDc1ZTk1ZWVhM2M0ZTNhZmMzYTBfMjg_11faa71c-7ffe-4059-a671-fddba93a94e4">Mountain View</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8xLTAtMS0xLTQ3NTkzL3RleHRyZWdpb246NWQ2OGNlNjk2ZDJhNDc1ZTk1ZWVhM2M0ZTNhZmMzYTBfMzI_403803c2-454e-486c-92ca-b1d63f802ce9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6MmNhOGI3ZDM1MWQwNGI5MmJkNTcxMzhjZjMzZGY3OGUvdGFibGVyYW5nZToyY2E4YjdkMzUxZDA0YjkyYmQ1NzEzOGNmMzNkZjc4ZV8xLTItMS0xLTQ3NTkzL3RleHRyZWdpb246YmU4NDVkY2M4MDdmNDE2ZmFkM2U5YmMzNDUxZjFmZGNfMzI_b4032e62-5acc-462a-bba6-3079007a637f">94043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjM3_41a9ecbf-b16b-4845-8b18-7b5e20865bd0">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQx_a10271df-dfd5-4f29-b177-4596c6312788">237-2700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQy_75dd2df6-9ed6-4eb0-95b0-67123ca39ff5">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjM4_ac205e1e-850c-4c0c-b13d-c60c9aba7c3a">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQ0_6d35cf58-ea0a-4129-b82b-e34f787e4cb6">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjM5_a2bc9d3e-5430-4cee-9fce-b4d6432d9478">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6M2E0YTFhNDI5YmRmNGFlZWEzNjQxZTZkNGRiN2JkYzEvdGFibGVyYW5nZTozYTRhMWE0MjliZGY0YWVlYTM2NDFlNmQ0ZGI3YmRjMV8xLTAtMS0xLTQ3NTkz_105ae8ea-c440-4d45-9fce-b2e2f845f5ba">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6M2E0YTFhNDI5YmRmNGFlZWEzNjQxZTZkNGRiN2JkYzEvdGFibGVyYW5nZTozYTRhMWE0MjliZGY0YWVlYTM2NDFlNmQ0ZGI3YmRjMV8xLTItMS0xLTQ3NTkz_7fa3bf73-4c6b-47ae-be94-0cc578ac4fb3">NPCE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGFibGU6M2E0YTFhNDI5YmRmNGFlZWEzNjQxZTZkNGRiN2JkYzEvdGFibGVyYW5nZTozYTRhMWE0MjliZGY0YWVlYTM2NDFlNmQ0ZGI3YmRjMV8xLTQtMS0xLTQ3NTkz_382455e2-77a1-4cb7-a7be-73c0ff72cbfd">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQ1_6bea7afb-bea0-402d-a9b8-5898673b066e">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310"
      id="id3VybDovL2RvY3MudjEvZG9jOmZlNjhmNzA0MjU4YTRiNzdiNjlmZjBlN2YwOGQ2NmE5L3NlYzpmZTY4ZjcwNDI1OGE0Yjc3YjY5ZmYwZTdmMDhkNjZhOV8xL2ZyYWc6OTcwYTM2MTM1ZmI2NGEyMzkwYjJmNDQ3NTI2YmE3OTYvdGV4dHJlZ2lvbjo5NzBhMzYxMzVmYjY0YTIzOTBiMmY0NDc1MjZiYTc5Nl8yNjQ2_4f1543e9-2968-484e-bd47-13fa2776ab55">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M!C[F/H#W2Z7LL>'.O\6_+P;_ %!+ P04    " #7@&I4GZ ;\+$"  #B#
M#0   'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^5
M6'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0
MHW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<
M2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ
M?$,78&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>
M&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3
M .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*
MQ+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*
M6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0
M\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1
M.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMH
MD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^
MI_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E
M\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!
M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    " #7@&I4!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -> :E0^'IYS[P
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( -> :E297)PC$ 8  )PG   3              "  <T!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ UX!J5*R0W^]*!   RA   !@
M             ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( -> :E2?H!OPL0(  .(,   -              "  8X,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ UX!J5)>*NQS     $P(   L
M     ( !:@\  %]R96QS+RYR96QS4$L! A0#%     @ UX!J5*K$(A8S 0
M(@(   \              ( !4Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( -> :E0D'INBK0   /@!   :              "  ;,1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -> :E1ED'F2&0$  ,\#
M   3              "  9@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  .(3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="npce-20220310.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://neuropace.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="npce-20220310.htm">npce-20220310.htm</File>
    <File>exhibit991_q42021earningsr.htm</File>
    <File>npce-20220310.xsd</File>
    <File>npce-20220310_lab.xml</File>
    <File>npce-20220310_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "npce-20220310.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "npce-20220310.htm"
     ]
    },
    "labelLink": {
     "local": [
      "npce-20220310_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "npce-20220310_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "npce-20220310.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "npce",
   "nsuri": "http://neuropace.com/20220310",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "npce-20220310.htm",
      "contextRef": "ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://neuropace.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "npce-20220310.htm",
      "contextRef": "ia2ef8cf2fd274038bb4212ab1df46bf0_D20220310-20220310",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://neuropace.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001528287-22-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001528287-22-000004-xbrl.zip
M4$L#!!0    ( -> :E27'XB\B!D  ($Z 0 >    97AH:6)I=#DY,5]Q-#(P
M,C%E87)N:6YG<W(N:'1M[5U9<]LXMGZ_OP*3I'N<*DKF)E&RTZE*.TE/ZF:;
M)#.I>9J"2$C"#46P"=*.^M??<P!2NVQ)EFQ28C^D;9/$<O9S\ %X\;?7GZZ^
M_>?S&S),1R'Y_*_?W[^[(D\:Y^??G:OS\]??7I-_?/OPGKA-TR+?$AI)GG(1
MT?#\_,W')^3),$WCB_/SFYN;YHW3%,G@_-N7<VS*/0^%D*P9I,&3ER_P+_ O
MH\'+_WGQMT:#O!9^-F)12OR$T90%)),\&I#O 9,_2*.1OW4EXG'"!\.4V*9M
MD^\B^<&OJ7Z>\C1D+XMV7ISKWU^<JTY>]$0P?ODBX->$![\]X5TGZ+4[;J?O
M^<SM>RZE\*/%O*#O!EZ_;_W7@D&>P^OZ&YF.0_;;DQ&/&D.&_5\X[3B]O.%!
M.KRP3/.7)_/OT60 K_9$FHK1A=DT.W$*;_1%E,)($FA9_Z@[6.YF[G/X]C)E
M/],&#?D@NO!A<BR!UOAH0&B8_O8DBN5_0S$0/V]8KY$,>LT![S\A,O'7/M+=
MY#-IV_'/R_DN6]#E-4M2[M,P[U:-0#_.IVVW.O'/551:-5B<;_'<%Z%(+IZ:
MZK]+?-+HTQ$/QQ=__\9'3)*/[(9\$2,:_=V0(& -R1+>UR]*_A>[L!P8G_KU
M1D_!@W9"'K&".9;I 4<^LBP1GZG/R!<6BR25Y*W(DG1(_IG1!(9%?GWJ="[)
MVRP,R7\835"F+/*61S3R.0WA*YF%J9QGEOIG#2,GS_8W4_NNF5HVS/2#R**4
M\HC\F[,;@UP!\?O-8FR''9"[<D! VHYM69<?:.(/B64:6E_SOY()9PSR+O*;
MY.PCE0']\]>G+>#'Q\]7;YX;A!)?C$8L058T9$H'C(Q8@!)) G;-@:OP/*;1
MF/1!Y258#!&1% U27R0CM!WID)&07\.L1)_$3,0A(S+K]V%*\+2?B!%A,0]9
M+,<&245 QR11@@)M]2=2D&@I@%X2U6)?R]"?N0S1"%Y&"1JC!+$H@(]?,Y^-
M>O#0L=3$K68%9.@+0V4E_X _A?CG9;DO1A33(  *-D+6S^V@TG@.<X_2BX8U
M-78/+78H7W;[\O$D_W*.-I;35+3X)E(E2-<LRA@*XS.WU;0)]!Z"ZU22A5)B
MH/B!N $544 IZ,TOA$?H$"5\!@897S-KONR++^\BB%V ,WP4AQ2&-,LAQVEZ
M=W/(KCET4 Z!XP[!3:C <!67+*O9VD"/[%_ 9RQRB=1LVA>;K)9)0F!+2%SE
ME1,V9) 87+.)@R4Z$I3J<<C0Q=*(?/GXE7P=RY2-)MR%(&8U#]U:TQ[61X%N
MF7.ZM2+Z@?=6V\5%9N&W<<*A%14GQ3!P$>3,KKGX(!ZMLV JMV#G<B"RDI\U
M'Q_*[]GWX&5WT1G6O#PP+WT&KC @;U^_(C2.$W$-&@KL0;J_>_U&,9"2F%\K
M$RS3+!BC98QIRH&DDMQP8&N09 /,13FDPC OX->()F,R8!%+(-W_"]HO?&W-
MNL.R+A538TA!@; TT:,I*-V8A+S/B!]2/IKHY4R0 U]&H&+AF%B64C9),B ^
MO#>.564CDUC6B )54ZTS\/WY12DS-ENH4>6HPJ(.,A[0R&<DH=&@2- G]A68
M]LSM%+^6JI)S"P_,RW>$CL!.B"S &8%S("FC(U6"\RXE83^9GZ&834-N"K8&
M0O:?,55E+!3>*%.%K-P'H0<I GD@"X;]6/\*&);9$OA$Y\.K8Y!!(F[ D$W<
M5<$+0XW7NB22\H!\X#\8>0MJE1KD:LA9G[S1 X5DXE._SWWMVB85Q"8IIEO,
M J9 0RD(BQ(1AE@7A*GW>2+3PJ3BC'$(-! ADZKLI:TN3B8I=!Y-\T3G<=2W
MV=Q):;,G8(XP=9$H.PUJ'RM:::JJL8":@K(KTN.?H,T?+"4BQF\R(-ZX25XI
M3H1"_" ]-@:#H,8+)@3>P2'@FL8-M".!9U+X7*V8*#^![UU]^O>[UPVK2Q0C
M1]PW<A[;V"IR!4=$?9^%,)&4 >6!#CA'T($A5^51'!F/KIE4U (J#!(ZDL!J
MR0<1"H<@*4T&+)WZ*4V]/DM4 _%P+#F,+%+3!XH (1EY\^%?$RY<BS!#L5<B
ME""#0P&*"](U(C*36-"FO; 0G&8A)J72P-6UU(5UA@JL*ZRV)/-)X0W8A_FL
M,->C=9'G?!ZH"N[/++/96?Q^*?ALDG6)C!K#3"9C+&8GNA=OIGBWOI/;HFS5
MD;W0T6SHK%8?DEP35K?_;<@E-!AD?F%GDSMZ!"O!?-#E.\8&0\(P >PQ_ ;]
MYQ8)XHK)\#)X&L*845TYF$W\/C?FP!^]@B*G)@,U#QZ%5"HC7X0ST)8_Q%4-
M_ B$"+]JD@\B@6Z'8$:Z0'I<7"E,P! ,-_RCS!5/IE:Z6++)YP^V:L@T6^9Z
M@A'-]V40,.2W$0T(K,TR"#_,MI]%FM;0Q$(7'!J?B *,1F02/LG;8\&$)*NG
M7 %E_2,14A*]D'M'4JADS7-^F1-BK_W+K0IMHD C)WWL&U\=S/:8L) J+[U.
M'U2G4V8%6G1I--5=: 7<NUK(](5$CX*M1UF?^FFFG(J(T6%A; S]P=]R3Q2)
M9 3&0I4@T8^%H;C!U[4C5"-##G.99+'^.J\\E6MA[C8CG,\<)H4V(I)3:5['
M8@C(P-QZ36MJPB;L5GJ/MMS>Q$RJ=?+71<=K^E4&L]5T)@TN=.8TNZO[6IOE
MS"(M8J%Q)A>%F*W%7A2@B^DGM"<ATDB7/[D#D:'_'2;3K&O &CT0U1\-VH<I
M7]#PAH[EDZT@(G>C0!Y'RA8<%YO3RD4)6-!DC-TBTALO*C.$?.C[T+2R4,3*
M@&.PAP9$I;LZZBX$NDF^_J$Z>G6'J,U:,11B;YW,>3/BN%Z^%V>[-(IUTRT^
M"B;F:CX6G^HL-$!)G/5"[D]@"SK"+EK0(?@T'YC5]$JXGX^0"H3H#S17S(7E
MT]OBQ%DO1$E4-*3R\&9[HV@1VL-491NYF=HC@_3!J&P2T56 #U=4#H&D\"]A
M?V8<DM=)<J8E2^54$G+J!,PCQH#:45BM&5+CV]-DK">21#G4XF6W.Q/$4\6I
M2F)>5$H\3<S^R.M I1KY:BY_H!%X(PV8S!,!J7/R'PQT: 1&)4-15@4,#&@'
MRFBA6$.(K(.L= QI-G VBX)IL&1UL5C@AUE00*@2+G\0<*;0&MB\",9_#8:0
M%D*E-$6DN+Z@\S4(UA"*-10RYA"Y&--*@'J_R/Y[#)(%4# %^BH]Q76!%6)?
MH>//"U6WQ;<@VU>UI9EDWUXO274%=W_KT^9<B=:RUI9H:Z(?8CEYCOHS)9F:
M_ ^V"CS+ OL6#E3*FL["L6M+^C!HU$T7NVJB'P)JVITGOUV3?]_D?^6KTN3J
M9<SI8CX&RS\AST\9+M&;\_513&IJCCR0;YMGQ;-VK1+[9L#<<D%>+QGQH.&!
MV"L<1$WJ_7K<%15\M/Z>.V?]O?:T*G4SY)"YZVP<BX/S.C$?@$]]"#0:B:BA
M*D R%?Z/1B^O48ZP6PT\R(=0JDAQ=8WF.^O!5'3A^$I$?98PA.I<40@3WT6X
MUTO-J%0S65<A+59#U0+N4."LL'Q3S,G'.0$S R[]#)3SSNUFJIJYO%5-K4X4
MN!(_% CTC,AW%D1,!G1LD/EM>0:A*7%5'<8QR>?FAR9Y Q1G241P_EA>11R(
M2'#)21=:F<)NAQQ^BE2=2%=,%^<RHF,2"%S#[<$/,$1\]ZSCNL])M]5JV);G
MJ.)P((#,*=;&X2OTRO"WLZZ%KW6\AM=UN^HUU7M$]7[CXETCWRD\T_>[UWHG
MH66VVI;7:9+WZ/QI%G!1X"YO<JE2G.@ACH_R4%5&A3:%$U11/O4)2(E-%ICU
MC%4Q?X*J@G8E3Z&]5 \!MT-+]>.O3UU/_\.+-IL12D2,*"9H1SW3JQ%+HP-V
M*4P2LG\Z5*2)6AP?:PQI2D*&GW5- FPNY "'B8XUK4)%]E5/9.G2_M!2#7RU
M<O^N;"PHQ<J]N,8,%(++A]W;BKJG0"AJ 3TA+.30A/9$V(SP_2S1BJ.0(3T>
M\E0_EHS_E26X /4.S$HD<(>/0FOQOM*U5"]VS6[CR:V6*HDJP%L$OFHZ6T1I
M%/)KD%X"A&I !['0VX5 EE.<(J)+T@)7*''Y1:+.(^0. >U M128!R1A--7+
MBJGJ-Q\P6)PL0=B&0N!,&O5IE /-*&@5@D((HJD#FBBPAP^1O@;Z%7"6!8HB
M!KLQQ6!/"(SS'%*Y4 I/T=CTT6:3$0)F9B=!U(ITL=*2@^,0'9CZ: H+>QHB
MP@Z:C+.0%E9GW> $?)!HBJ(#$4D _95,==:AY9(;9,%[(7[@=+Z"]*G$H H0
MN7? PD#CM9%K/>K_&*@E%2T5' V]4FP^C54,8*X"+C&).)8PQY,ILR$+S]/7
M5&F$.57DA"J%*])A'?0[L2T3-Z0U.LWQ9!HQ8Z!L,_0K>N&F!]K%^G)VN6>Y
M(4S,Y ):M 9LE &PL3%FUY@LTTU%J-AV@!$,59"H0NS6+(D6,D=[8*A4D"*5
MK5PCH@1-J<QZ_P?2ITLL0^4O9A8?.8.1X=IB/D J93;*T5G*^F,3Z&BX#T$M
M-@+Z CXR;9)7?IIA0E582PT\UK&O+[*P<% $4Z5$>YT";C8#@D18F4CDXGJG
MB 8"?YY=)\VCO6)UL[\.9JT0]!"SP?_54T23XQZK<?ZI@>K*89@]#%I!_0M2
M*E>I++@BB?I]CE9%&@@]8SP/^:"?\![HO_(MF!*,BRR^"%'5 3A!P=@ON(S[
M5D]YPLUH\GBZH#S1_=<Z#2F\U"OP76/P?3C]J8!<%;M5U#LYM!E?^51 ]68[
M8Z%D-R@*.%:D0XZ)Z?-0PPL*/.J_FE^;Y.L4I( ?O_GI#]4&C2L()[@>V-G7
M-U?/9SF(C>;)4EB<YX%$?XL!@&4V_HE]Y683.*-D(4^$+$-U_2J*,H727OST
M?R= EMO.^E!>@.6]3.8#PYR3#HSMDOQ4&B7M/%79$GXV]]4$RI*E$-@TR=OU
M.I=[$!V&*@]#HTB@%.D0*6%3ES'CC682"ACZ-$[5N [L.T"KCUP3_2:9>4,9
M$40<8&Q(!'!R0 M'F,7J*YFI"L:T,_;39W&*C2<(3\':JK9%-(Y!$M0P0GJS
M@8F10Z7JD4 L ;I1CFW%&I$RM^EQV:U=0VPN\QDB*_*Q]B2,"6F5QU_JSXH(
M2^X:!?+6$>36*H_:-/MT'H;A-";/8,L+"J-G5E;'()/L4#$L@P!0]Y B$!I$
M6FG:>#UA-,R<0L*H/ (&WZ@<2EL$FL0?Q0/=D_HF8#[7BJ[R+WPZ@Q":VV]3
MJIAL=4!9).UHG%*P>+=!3!X<I<W#$5@G8-(?$";&)1G5!YJFY'?J2P$9Z]M7
M&XZJU79\ZX"CXM/B2]N]G"N6[""%JY_==6C9FJ\V.T3.77F(W%:'P]7A];WI
MMM</5Q[%MU^5=>\R<G9KMIJL:V1;"_8#&F4U7@P4<<DAF,GOY^+$]=N='XD/
MF\WK+(NPLIRRX/G#2"!\F&-X"P7'4D\#YAO26+*+XH?+@$NL#5_P2(U:?;3+
M08^@K$U3*VP*8TV#HN?\<5,].D^#Y6=NI]FVG;6/S::U]MEMS5IFLVNU=VKV
M]F=.RZ[.8+NF6YW!'HJR]F8#.E>2JZ47%$1"RO[;$V=R%&J^;'MA$DLI6-'>
MY-7NTJMV_!-?7K9#BPJE=6G?UJFSD7'Z-DP8(Q_@O:$D;Y82UHG=69SN\5-&
M(0SOH,@=0C.M]3;R0??5?Y>W$ )Q 0],!M7@!4+QN7][T*W]F2H>B P:#:11
MY.MRB-FHPN_CJHG^;81+7?+Y!E*4^ZA4Q!<6MB9"'A"<W&VT*I_0S$' [C/;
MM=ITC"0S]V%FCI$PM2S=4Y:V-M"^SUA9#+1EWE4$49/^HD&1BZ)RUQ0W8[E)
MJD""9P>:_.RDU:T"I9JU91K=KO?K4ZMM7AZ& /AH2T+L8,)K23T!2?5:=G4D
M]4Z_4(OPJ8FPVS*LCE,=$:XE]60EU3(LIU-&2:UTN61#ZE\A:%_TR4"(0"(!
M@TURN!UF7C[!LXWN1AGK-GGID1"FY3C[$(.3H9AE&9[;J65I92C=:;</4>30
M+MTIN7W5NQ+C1/1YNI-*W>7I[BAZE4\B.H;IM0^M*D=(-=OJWD> :G+.DM-Q
M#-=IU5*X+=E,P_;LXUE37)KVZCK]IZ6=SF6)CNHV#MS&::S(2*8V4.N[#R9G
MF^[#W53"K+4,QWTH9U IPCA&]_&CCDI1S,) [>!5A4I2IF6TNZTCCAU63_LK
M"T.U#R:_TT#O#0Q&/.(R3134_60J;JI,<O#<KXJ4\0R[LQ%ZIBZY%:ZI8W3;
M=?EV5?G6,]IVYW1+;NM.IZK+;\H&>X;9?:@ Y8C(9AFVN0GPLR[ ;99R>8:U
M4$FJQ?!NLKF.X=C.(8+H:MCV][B:HH\'6MYFMX-C/Q[)..L:IM7:9._"/@*B
M(Z*;;70[UD9[/@X9>Q\301W#<[Q:$K<FG.489FM!%$^A_CRY[8A'>/[1R92=
MK<Y#K8-7BBR;;2.J*\Y%2'AXX%$ER6*=7*EYZ=:XDRDLGUE&IVT_5,A1.=)T
MG$>/;ZM%,\]P+;,6IY7B9!ENIWUZ0>HG=9BECE#)66YAGQMXN^?)!*QGAS>Q
M522+;6\"'JDCUHD8M0QGLY++R9'&MNZY<%?EXFYQX_+&N\"V+0$=VS; K>=?
M;N$_LTRCW5V.5?=9 GS,+:NUN!Z7N+I&V^I415JWSNYJ,3X1,7;:AME9SG9+
M*L>UN)ZXN-JN87LE-+NG4 0I(O390Q/3-.&]+"WN6\"KL41$U$6-0Q$&ZD:[
M'I7<SV_:PI.ZEPX9V +! UD,"42&W9W@.1^WSK[DFFLV77=SO=UN[J4[C:86
MTZJ*J6TWS6XUY/20!W_5 EQ9 6Y:R_"K4LIO+:8G+*:6Y34[RXC51Q;4O5;<
MS16B-W>W?#<N%U.^JU]8T* P*KS&5P7YDF3Y9<!XC6^F=M5$ATH%)D2W-P9_
MYI=_+(K#?:Q$^?0%\EZKW39:YK9'Z.Z35@]C_FL16","9M<PN]L>3%M>_N^.
M.*H%8QY)W#;:9L?HF.;1R$8M MO:!M<PV]N>HUH&_JN(ZUQ%#2^WOI'0>_*R
M##?KU5<9UA<+[O]BP=]IB'>5DZ]#QM+Z.L&27B?8-9NNOF)NV]L$/:O9:GG[
MOT;.;MKMW:[2N_V9:QW@@CX<;.N![[S;!8M=ONN#ZGO>Y@S-0>YYVWHYN5HB
MM.FE7;N3X2![>RM'Y&.^YFOUI%]).1NS[//4CKTBY@]RKLB>SA(MDUG>]#Z)
M+$E  0G=G?V;UH".X%C8:N#RKZC49\/Z^ /[,^/7-,3KSK==NCF!M;D*+<!9
M7</J['@?7X4@#;70E6EN=MMPNMM6J?<H=">UH>KK4"1I Z+A$>'1-9/I:)75
MWE,H4CY9ZZ*L>66)02I!,LLRVIWN(9*5:FC,*]]7M0&2,)]!F-,+3^<XHDT/
M!JTW,D\OY7$.<Z)Y-93E'?B4*!7)^&0\BF=T[$T.+:T=2D&QMM$U3]B??$Y8
M3'DP.8-:I=%"'27BW[]24D6;:1M.?:7(=C&987GW5*%;O(S=*KD*Z>/<]Z M
M.VP$++E@.+;1L38Y0[(^NG8C@K9<H]6^Y_5VI5ZJ6>>D\##M=*R<$Y9WU>U?
MIW6T5=O<[<;C4W5*+>OTKG+ZPF2:<#]E>B7D/AL7*@@PM>P=@>=EQ(\?6YKE
M'.:.[5*KXVO69Q 40C[5AQ]P3Y(OY EE4K\^[=B6O:2.M=NZA69NQSTYMZ5/
M+MT?(*,2C+X?K.WD_,=][Q2ZI497D0+#:OW8&0&VF/L>*?+@6$Z5LAP'4__=
M< FE.=%O?X=_U,)<86%NM8QN:T>,3?F.22MUQ+4:^_R>TQX/><KS!9^O,R<@
MJ*C=NR1O_LQX.B9GD,5PGZ?[VHRP;H/F8Z-HMQWB*22P!58ZG(I+69*YO;=Q
M4L"("8HHIN-5$*)[5P=+-^.MCR.MD#NU#,?;<5]]B4J?M<Q52>:Z;O?Q).ZD
M$#I@JY.,!?MVPI6H^GA&UZZ7/;>#LRTN%)]48#.SH2!@O?7H@.-< <T77"H?
M"APYFVS#=)WC\)X5J9W[^TUDCP=0UC4<\]&W5!P3.5N'V6]1:AV;X!P2C<H3
M4:YO)[.8V[7JU=PM*Q;F/:^_KF Y];V(!AO$IL>6DKA=H^/NMLOU5+.XEFET
M[-.['_X+"Q@;J;/Q?!&ID>'/<5(X&'52-[FA24)GHKG3V=YW'T3=J?H:IWV0
M[7VE5B2-J#O%BF&-.=VA'N$=!'-:I0+!?55E&410\4RV;1IF:[=ML(<!952=
MGK;AM!_WD,6[#F3.VVU@(Q?6Y(CFF9M@2AT6&N093,2T2$P3<DW#;(IJT&>"
MGW1EJB1^\7@(:KF6X=KWW(M;P1QM%520Y5#!8 ]0P;+@ 4L!^JNLR=:K6U<S
M]VL=PCQ7RF#8[F,;WTJ1:Y7#.BDHPRL8,UZY MD)GM#3P,OM:(RGS9],N<OM
M>D:K/L]JRXUR7:-C'V2S=47TQO>S4192/ 4A/\A*C"!7&+)(\FM&> 2_G\ZA
MB6>V9^\6D)VJYW%.&#\WJSQY-'\RWN;,M1W#\ZS2I"_5H)K3\8QV=X%J)X@Q
MDX=*C(^N=.(Y1NOQ3[,Z'GJ>6:YG=!S[GBIXB]]RO!4J.%=J<)LKKJ(K@5;.
M+.P8)-D,7X [8G?1Y@U7,^Z^Q/2T-K?OF3KEUM7=SG'8+XE*OM&O5I-:378Z
M(:(<6K+FMNA\U.6XA_F\)X(Q_&^8CL*7_P]02P,$%     @ UX!J5!,:.:"R
M%   $(D  !$   !N<&-E+3(P,C(P,S$P+FAT;>U=:W?:.+?^_OX*'>:<F72M
M"&SY3MN\*PV$H5-,FI!DX$N6;,G!X MCFP3X]6?+AB20>YN4))-^2 ')DO:6
M]K,OVI(__7<2!NB,)ZD?1Y]+<EDJH?]N??H?C/_^LO\-U6)W'/(H0SL)IQEG
MZ-S/^NB8\72(O"0.T7&<#/TSBG'^S$X\FB;^:3]#1")DI3"I.BY1-%/1L&K*
M#E9E3\.FH<%7CUB63@Q+X\;F:95[JJIP0\$.UPA6'<O$CBJYF)JRISNZ+%&#
M;+*JQW73,R25:"95'<-P=,OS)&YXDLETG5JBVWX&U &%45H-_&CXN=3/LE&U
M4CD_/R]/G"0HQ\EIA4B24A'%#DUY:5Y=E/IWU/>C-*.1>U&?\<O:><V4N^73
M^*P"!? $D1<5_4EV<[-^!&/@@NV5+*%1ZL5)2#.8%O&XA"6"97+9R&U#DY4K
M#5T0<XWX<R6O+UN65<E+YU5OKR18>=%>ZM]4$1@C5_YN?3MP^SRD>)5%0#D&
MKBP]N>#27<3+&I9,K!0<K 8T.OU<XA$^/"C!!'/*MCZ%/*-(M(KY/V/_['-I
M)XXR6+:X,QU!]V[Q[7,IXY.LDA-2V?K/?_[S*?.S@&]%(Y=CL6 E198^58H?
M/U6*IIV83;<^,?\,I=DTX)]+S$]' 9U6HSCB, !_4A45>5)\]!GC4?X1RFV0
MG<1WB_XGV3[W/I=\2KAGNA[Q&#%423$=1R4RH8[,/%5W/.FDMAC*Q9A****A
MZ)K[U7H$XYON #D)#9H1XY._^+2$? 9-,^5HZM3BLV]D_ZRKM,9L4#_K-:Q!
M.^P%]J ?VK-MJ34X5+N=?=^>,=\>!&%O\"6P2?>\W?A.[+"N?5/LH#L;A;U.
M5^T-W'.[UI3;C;K4';A*=]#5>F'WO-=A8:O6']J#7K]]9$K?2&_:/7;U5F>H
MMFM-R0X/H4Z+V(U#N1?NANW:Z:Q[7%?L1IW8,ZC3:9VQQJ[O- [UUJ YL1M=
M:+^I]8Z[FET;3EJ-NMSK#">]8]NW&\VIW3CRN^'BF2/H2XMZG7C:&M2EWF#?
M;PV"H#<82NU._;S;.0K:G=V@2YJB3:EW_-7ORN;YMTX]:QU(DV^=[XK=&<Y.
M+.9JAF=YV&"$8553%$P]F6*/*#*S/(>;GE;:DF!):\0DIO&ILC2ISSG'VP"Y
M3,#N;D!/2ZB0!6AVDE4]?\(9]F@@D.I]TN^>],FU25<42U)<QK#A2AY6.4R
M*5$/$T=W9=>U-,]P2ULY>Z_-=V59OA/N\80#O*4WP)) U&J:PR"L")0C;#4#
M,/I<2OUP% A,S'_K)V+!+"%0>9(R:**RW$;1_V6G\S&D\3C)O^7ZJCI?A<7*
M^)%5N&B(YS"S^.8S\=WS>8+R ?$;,7RG^=>RP*P^O+7X:;GU$? W9HMOH#.2
MK ;&QI88%)84+$!YM>QBF.R6JHN2Q?=%)Y4E1BVX>L'&RA4\KP#J%]"?L_,^
M>^-$+EU]9JXN0C_"?2YLHJJBC[*/YS[+^E59DOZOE-?;^I2.**PH)ZG T\7G
MHI&+IFZO<J4?H5DQ4)10-ZNFXS"DR?2C(!'3P#^-JB[PG">EHJW%0VX<Q$GU
M-RG_]]$#G@"TA'XPK?[1\4-8V38_1_MQ2*,_-E/0RM!)XGM%Q=2?\:JL DGY
MU_."1@/:$9I\0;-,!*&'=K-3KZ&#SG:G?G K"2]EM ?UG</]9J=9/T#;=@W5
M_][Y<QM0#.VT6ZWFP4&S;=]* G#]%";<B;,L#J$YZ._YJ2(/HNIX^^#/IMWH
MM.U-5"OOE,%$UU3K,93,?\KBT:^BS'P09;OM_19Z1G6\<((*8W*=2G>R4+KM
MC@M*KT5:G18HVR8HW?JT-1N>=P=?0[LFE%V3=,.ZTNYT08$>J>S/KT&/!&?.
M(-;LV9=^:]:=M&9'(?0C=3O-6;OSQ6^%7<FNN7)KT/.['5>S W-J#[Z?GY@:
MI0:C%%-J&5C5#153V=&Q0QF3F*/HEJ.7MDS\UW65N39)EQ^T<D#.]^MV!^W7
M]]K[G1<_W+UQDHXI>.-9C ZX*]RCWW^3=>FCK* X0;*VP3Z\+&AZ&%VQA[(^
M%R2-$S_SH>'ZQ.V#0<71MILA*)8M17V-E D31(Q_GX_B)$,;B^^<@A'"TPSQ
M,Q%=2?)BSCY4?P6.[>6F4+TPD);="P:_X!#Z[(O',*-3/(6Q8A[]RX"O-6B=
M@+E'N66YF,F.AE575K$E*Q)6'"J;&J.JIX'!W**)VT>RM)G'O%X.!!+]02OT
MV4,5^_S43T5,)[.AY%^VC.Q!BYPP1W,=6=:QQSP=]*?L8:I*)I8DSU$EZG!3
M-DI;=OUPO[VWO5/?1$U[I_QR%I(LK2PD]<:%M%&?@.N13[] N.1BVA%-43KB
MKG !&?(CY&<I G@'P$NNJZL'.3O+B \+'6C.J!/P104G3L"%PT![0$<IKRX^
M?%Q$[XIX(\X?^KC<G ;DGO$D\UT:S!F;\[@HOG3@RE+AQ&7@*F9LT?.\N)P7
M53)VO4PA9:(HMQ9+9?G6LG4UJSZHV4K.B8(;P' Q=Y]+2FGQP C,13\ZK9+1
M!,G+.CK@WG6>QZ/2TJ3/G\?Y!D.5E TMG_=UJ/7"ZGH)?Y\=OIN1&R=@G>3!
M^(,,[(.=>!QER70G9LO&@XA B A-QD=)?";:>:56PSQ&&=K]=J.I]&HMN77\
M_=QN-+56^'5H=UR _OZ@-VC->HVNTFX<7HM1=DE=[0[8L#4[G/1JVS#&X;0;
M?I?M67W6;MAA:V8/@0:U=R0"T]M+,<IORG[ _]R?]H[9R"&J;L]<4"_]8>^X
MI78)\*+VU1?M0[\2C G&? AT[ :MXY[7&IR>:)QZU%,E;)BRA57-,S!U70E[
M.O5 X1C<,!0P3'E SVER0Y3S%LA=2)\050 ,Q0!!69;(^8\O1A_EBU7X16UP
M+A+T%7R+E/FYU_1VJ 1-NR2A*PIU@=GO</Q&X'C7#SBT[L"">X?6^Z&U?C>T
M=H8P5NBGLST3_<+89P"AYZU.5[,'NWV[=JK:@^ZT5=O/H=4PN$(4B6+-U4RQ
M96AAD[D<6QZS5,*IP8DD=D!D#/.K7-\Q? 6HLQI+O@5;=^(P]%.1,X+$BD3%
MDOR WM'GC>).ATZ:\WT\-U<T[R#T8!!JW@E"W<%WI5UC8:^Q.[!)$\91U[JD
M.6O7NC"N0PE^'W8[_7ZKPP"$W!-'4DU"'!VK^1:V(:G8<:B#74ML7\N*X^E&
M:8L0K&B:!&CUAE&HN7^ ZN$HB*<\>3MD+<L9LN/R34;=N[.]9D3<9BSA:3K_
M[QL,6WY'P_O0<'*OMWO\G< SP*<AZ=6^]D5 M=<9RKWCHSY0)/4Z=K\'+78[
M7[Q6Y_L)<4Q-D<$0TPR'894SBAUB4>QY$I%EV70D72]MJ9J&[#+ZPI.()BQ&
MVV<\&O^@[UO(PL=7+R#K$)8=^-A..O'Y>V#H%XL*>"^R[%%JR"XV/(^#AZ)9
MF.J&C#W&'&HIU%*Y6MIJB>@>]2-TY//SVR3D>5?YS6IQ$_V:WM>T33:7D#QH
MU4[VDOC,SU.GW\7D5XK)K'DB9E!27 +^O0IB8NHNMH@+:D5FNN*9$G&Y5=K:
MV7Z-=O4#(Z?SM2BV\48)+$-_1 /$)]P=9_Z9V-T#XY2GCP\U2L(4+;V]N,#-
M;'P)<8%[U/Z_ %#WXC2C0<\?%?M5[W!Z+YS>$ZX(#U6[=C3LDI;:JC$8;YWT
MPMUABQQJ7=%2#?H8[(:]AIW#J0,32+A.L$9=%ZLZH2)<H6-%,BQ),JBN&%YI
MRU(E57G#B KK#XD%>*LG7\DS$5YP[N'&,PJL< NV$TY?K8C^5(*0<J+*U.*N
MXX&-H3M@<J@:-AW9Q(:C<2*9NN8PJ;2E:]=B>1^>,UWP6PQZ=J\?1Z]YP^FG
M4I\G)U26B '\PLQCQ3E5F"/# -O0TEU=D8EAFJ4MHAB8@-BL3@]Z\4E;E\EY
M?Z0HXP$?B?E&43[AFPALOV L8!51$$]878P_FJ1[4KE>"K[9<8:V1Z, C$L
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M-*().J/!F*.1N,*P?]?!YR?!AG?!>*!@S#&Z@.AWJ7B 5"RG9YT8'E4<SU#
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MXVOR(RI.S*;P7S\+@ZW_!U!+ P04    " #7@&I4Y/)M&6L"  !E!P  $0
M &YP8V4M,C R,C S,3 N>'-DS55;;]HP%'[G5WAYGG.%0J)"I5%5FL0VB;5J
MWR;'.0&+Q,YLI]!_/]N0<6E9A[2'24C8YWS?N1_G^F935^@9I&*"C[W(#ST$
MG(J"\<78>[B_PR/O9M+K77_ ^.G3?(9N!6UKX!I-)1 -!5HSO42/!:@5*J6H
MT:.0*_9,,)XXTE0T+Y(MEAK%81R?:F66TS@9C)(![H^B'/>C<H!'PX&YEG&:
M7L7#= ##CXL,RGX_@6&"<QC$N)^G(YSW0XK)*"JO\JLH),/8&=VH3-$EU 29
MQ+C*-FKL+;5NLB!8K]?^.O&%7 1Q&$;!TY?9=P?U=MB*\=41>I/+JL,G@57G
M1$$'YPV%WW .K10-H>!340<VUS")3#&)UI+EK88[(>M;*$E;Z;'7\I\MJ5C)
MH##UKL!6] APH-9$+D!_)34H:_\]CY,>0K8*K&Z$U(B_XAV4(4K3--C8O#RT
MK=I,4*+=*)PM@\-C>\11C)/(WZC""_[*[;$AQI4FG,(EOLT-=[Q_$<.^IY?%
MT/$NC\$94T#]A7@."F"V<]';[M4YN#U@>SCV23@7VO&M9"=K&L9+L148D0T\
MZZ*?0]FMR:O9?V-$W%]&))6B>F>>@L;,)DC-0!WNC3.PE%"./;L]N)O:'Q7)
M?1-)!WGEX+@%5AT8"E2S?28=5[\TAJM, RK8UN9_3KR1<&GBAJ+,>^$:?6'^
MEG]O](@58V\JS+OO(2M[F'\^\ZXXCUMD9ZHS5D#).'/C%IKWU/P0WG\?,'*L
MZ^ 4>V*E55!\XQ-W/LUL1]Y!_D"DI*)M=3EO']99VD[856ZW6<'Q:FWO!^OG
M!-N=GO1^ 5!+ P04    " #7@&I4X1O^-JT*  #_8   %0   &YP8V4M,C R
M,C S,3!?;&%B+GAM;,U<76_;.!9][Z_09E]V@6$MBA0E%6T&W4P[*#;3%FV*
M#G:Q,/B9".-(@:PTR;]?4K83*9)LD;)5OR3^N+H\]UB'E[PD]?K7^^N%]T,6
MRS3/WIS E_Z))S.>BS2[?'/R[>(]B$]^/7WQXO7? /CS7U_.O=]R?GLML]([
M*R0MI?#NTO+*^R[D\B]/%?FU]STO_DI_4 !.JXO.\IN'(KV\*KW #X+GWQ:O
M& ]0&*,0X!@R@*$*01R%^JT*DH0$41+*Z)?+5U)AC&2$ )-A #!+8L"PSP&-
MH2*,0)]&0>5TD69_O3)_&%U*3P>7+:NW;TZNRO+FU6QV=W?W\IX5BY=Y<3D+
M?!_--M8G:_/[EOT=JJQADB2SZMM'TV7:9:C=PMF??YQ_Y5?RFH(T6Y8TXZ:!
M9?IJ67UXGG-:5ISOQ.7U6IAW8&,&S$< !@#!E_=+<7+ZPO-6=!3Y0GZ1RC/_
MOWWYT-MD,C,6LTQ>FE_VLRS27'PM:5&>4R87&GWEK7RXD6].ENGUS4)N/KLJ
MI.IVNRB*AE>#,C$H(3$H_][7V&P$_#WA+=M8]P"N"O?COC!NX_3CWN!>Z/Y!
M'AYPK9G1D%<WU+M,3'7O/C8U&OKA$>_KMLA+NIC@MGAJI@9Y83XXUZ_6S1A'
M6SK3JIUUUUV#*N]+F0FYZBT;KKU4O#G1K^9"IO//A3S+KW7>X](DOPMS3?%)
M*5G,L4)Q$*H$*(@B@!,_  EA$D!?(1H)3I"/Y^7CG3V7&?CV=0.B:FE(,R<6
M498]:BWD,K\M^%.>NUYT)2^=MTRFBV<9O9;+&[J^0&,U0X(5_%.-%/ :5&^%
MU:O OIX]!>?,ZV(BMA;'2%3.&X 69K"0%\]YR/E 'IXDN-0A5"0L)7]YF?^8
M:0>:C ":%\"\J)2WP^VL]:N^+3:(:<%WT+ZVF/%<N[XI0>,7,&-(F]#*W.:&
M6-&I 9QX>:&_U"/>CF :M^A;[4H8=^\7]'(>)!Q%OM)=%0XAP"(2(.&!!)+Q
M1 DDB.)TJ-H;GH]-X(_@/(-NN**;=.T6L3,)!];MP/BMA-H9JY,VFYXFDV-G
M '4%=AO8B^Y=5J;EPULA]$^ZU+."4GXJ/A?YCU1#G"<B(($,(N!+/>G#(2*
M^E@GX,@G+!80!80-U>"VAHY-DBNLWAKL+UX%5U/J;0 /5^E6?G>+=E^L'5C#
M[H19R7H(&TXJW^IX,M$/":_>!PRR=^T2WMU?%#1;IJ9TLIIWS1E-.($( DY,
M=X!B#BAFND_0XV\1AIPC2>RZ@W8C1]H5O+OWGI!Z*ZBVG4 'HT,[@'$\32-^
M*XH<9-_/P0C)=SB=6.[]8;6EOL765>87]/Z#T,.(5*6K,NG'VVNF)X5"\(BQ
MF !,5*S_$ Y8G$2 $!*I@. 0R\1.ZSTM':G@-5JO"==;X;55?1_!0Z6_!]JF
MT;\]8PZ=P XV1O0$?9XG[@YV!-CN$W9=8-\Q?)7\MM">8< NTG(AY[$@+$E\
M L+0-\M'& /*8P;B(% A5S F>'!?\-SYL<F_ N7ERH/!/]@_O0W<X:IOL;=;
MZ&,X.;"V;>FPDG1?W$XJ;CF;3+A]8=2UVFOCFK??IPNYSB1QK(10/ $D,I4R
MGS+ ]/P<H(1%F H82V0Y2W]R?FSR7.<: ] Q']>(&YJ"W>B8)NL.8<(AS[9#
M'I%::\XFSJ;M,-H)M,/&7I3?M;A+F9FB^&VV3L3+.<()E=270$(SB*8J 2S@
M$@1AH*1 U!>^'*K,SA:.39YKD%X3Y7")=M.X6Z>CR3FP6"UYL1+LUMB=5-OM
M<3+I;@VHKM_MAO8B?K:J]6&YO)5%?:6404B%V3T5J(3I23&56L^4@@C&H60B
MB:'T'5>@6XT=F[1;RZLKQ/M9CFY3O5OS^R3PP/(?Q=V8%>I>4O:Q3MUV_K-6
MJWO#W+)FW7^-<\7\6A:7:7;Y>Y'?E5>ZK1N:/<P9XRQ$2 '!(CUY1BH$E.@A
M.E*1"*CN2$1@6S3O:N?8NHM-47B-U5N!]=9HK4OGG=0.KIZ/)6RB KHE5RXU
M]&U,C"FC=_J=NI*^+;B.8OI6<_M.X**@9B_WUX=KEB_F%,-(H0 #))6>E$N&
M !4) CA2(B2<H03QH;)O>#XVH:_!>2MTPX7=I&NWE)U).'2%;%C\5F+MC-5)
MGDU/DPFR,X"Z!+L-[$6W.23QN#/X-UI*/4X/)8E"/3 71.?<($@ A82 A"J1
MA F2-!P\[^YLX=A$^'A69(72TS ]@W.X'+N)W"W+T?0<6)[6S%@)=6OT3H+M
M]CB9<+<&5!?P=D.'1:=\D?*TU'W"']I1D=+%'&%$H8C-=C/* 18H!K%@>B85
MB9!BAE5,!N\ ;;L_-@D_(?0V$"T6G=KL#5AV&L7)@75K0X?=HE-OU&[+3FUW
MTRT\]8;26'KJMW+/MQ?ZTKG"DB-. Z!DS !F?@R8'MSJ,:ZD 8M9$/BA;9HU
MCH]-FH\YQ("S3ZD55\,SJ2T#4R70K<$[9<UZI*.29>5H\AQ9A]^5&AO?VTOM
MS.SM+"0]RX6<0R55H)39:XGUB)8P'R1Q' .<,)DH&G)&XJ%2JSL^-JF=5=N(
M-3C/H!NNM099N[7F2L&!M38P>BNQ=87J)+:&H\G$U@6_+K;.[UTKN!\RGA<W
M>5&M)%4;JL_RVZPL'JK;"D'!5!P0@!)B5G_TK))AZ8- A$*$H:*26FZ)W-K>
ML4ES7:5L8*[M]%\CM]3M$-Z'EGGWQN8TY=Y11#K4?@?1,Z(&O-W_Q+7@0<&V
M:\+#+AMYRFK][SS-))R'*L&^\ GPN9[I8HE\$"<8 D9YQ/7; ''E=,2JWLJ1
M=B6/QX76+SP#UON4N1ZO:A [M-<82=<T?84]4^[GJKJ8&'^HJN'UYYRHZ@JL
M]SA5I[&K\+_(RW19%C0K/^K?>IXHQ7VM;:!B,V_&" ,J% 0P5$1&4/D!&?P@
M@ZX&CE3N3R ]@])6Y,]('*IO=VJFD?905AP$W1WZ""T_<SBQC+O#:2NXQ\Y>
MO.;)48O/5WFVV3#,()10^!"$RCP;B\84))!( !F+.4.,PQ .%>YSY\<FV@J?
M5P&TWFG=(FZW6,?0<6"A6C!A)=*^D)T$VG(VF3C[PJ@+L]=FY%#:S/X_%1?Y
M73;G"$<1%A(H%$F &8H!\[D/L$H0C CV0S*X&-W3QK%)]/G@L"H?Z1FDP>HX
MA*X1:CF =J-IXN'S((;<A\YM#L8/G&L^?\ZPN1U4[Z"YP]2A[IW_D,5;9C(X
M+X?4<NOV1W3O5;B\_VZ0_6]/Y=RN:-WJN0U/TQ5TNP)H5'0[#48FBL_YLJ2+
M_Z0W544Q("A*?!R!@,#('&B-0*P"!6(N TY"DI#$[;DVC6:./5VLP'H:K5/1
MMI-9RZ3AS-?$>6,H5>ZIHY.)\=FCZ?;G))#.T'IS2+>UJ_S/9*;[D<6'3,C[
M?\N'.0JE#_5T#22*4W,BCP*S@ IB%#.J&"64"COE/VOA2$6_1NE5,#V-TU;M
MSXD<*O01]$RC\>',.(B[)_H1NG[N<6))]P345G.?H?OC*-[=\RO]^\FJ^A="
M+@(L%& \9  G& -F]OIR1O3'A#*<##Y5T]7 L<EX@]';@+0LH7:2N%O#8ZDY
ML(0M67%Z.$57Z*,>4-%P./E#*KK"Z7I01:==GWCKC)_K5Z<O-I^DJR?FG[[X
M/U!+ P04    " #7@&I4JLBI#>(&  #M,@  %0   &YP8V4M,C R,C S,3!?
M<')E+GAM;-6;;4_<2!+'W^=3S,V^O6;ZV=THL.+8Y(26W:"$55;WQNJ'ZL&*
MQQ[9)L"WO[*!; ADSX='PGG#S-AM5_>_?NZNJC:O?[[>E(O/T+1%71TLV1Y=
M+J *=2RJ]<'RC_.WQ"Q_/GSUZO4_"/GS7^]/%[_4X7(#5;<X;L!U$!=717>Q
M^!BA_;1(3;U9?*R;3\5G1\CA<-%QO;UIBO5%M^"4\V_/-OL^<*&,4$0:YHED
M21&3*?R9N+6:9U9!]L_U/B0I!62">%"<2&\-\9(&X@Q+VFM&7<:'FY9%]6F_
M_^-="PL<7-4./P^6%UVWW5^MKJZN]JY]4^[5S7K%*16K^];+N^;7C]I?B:$U
ML]:NAK-?FK;%4PWQMFSUYV^G'\(%;!PIJK9S5>@-M,5^.QP\K8/K!LW_9[\6
MWVW1_R+WS4A_B#!.!-N[;N/R\-5B<2M'4Y?P'M*B__SC_<D7DQ5<-O76!=@+
M]6;5GUT=U\@"]G.XKKO9PL&R+3;;$NZ/7320#I;5-O3V.*>"T=[:3[<7KOXR
MNFV@14Z&09[B@;OK>RO_9P?@NH,JPNV([F]?UN%!H[+7L_YR9>D\E,/1/$*1
M#W<]\FW7N-#E(@A%F:!$2RZ(5$X1'P(G-!-"2DT#LO9PO'U_6^SP('\+86]=
M?U[AC=$-G/5?>C$&V7]Z9.Y6E.?U^_YI.\>V.1AKP>,# BH%(J,TQ/G(28+D
MD@K!"="3NOVUM8>]_MJ91TU8U$V$!J>+>W.N"0\<^QC5NQ:KK6OP1B1<%&6\
MO[J?-W;AJZ[>@7*W;L'N+A<XZ@1- _'TUBO?'=PPL@XG41A:[L+C9] 4=7Q3
MQ5]PELV=-E1%G4BD8% %KXG7*2,* L.Y1DK.LIVX_H'940SP^3/P?"U?&(8W
M55=T-^]A7?1*5-WO;@-YB#CK*@7$QH1+(<<9W_+DB(6,":^M#SI,8N$IJZ-0
M$/-%8;*2LR#A!".S9ELW@_ ?4'\XKB^KKKDYKB/DW*DH8F9(T(IA**4B\<X
MB38D'B X;Z8M:R,Z,8H3.7=.=J?S++!Y6Y3P^^7&0Y.;+'HI64928*@+BY$8
MJAU1*G(! "$POP-&_K(X"@@U=R">J> LO'_NKD\B:E6DXC;EN!L(C6 4EQ@%
MX7I(I Z4F!0, <D\3YQ+J<P.4/B.^5%<Z+ESL0MM9P')48SH@O;N _,U8+G6
MTK,8+!$6^N716.(C6$*%#=+(Z)C;Q7KRA.E1<&1SAV.JIG,"XQB_OFO.ZZLJ
M9XXR;C&92AE#MC.+45/JRP$R"@R=C7*PBWGCD>%14)@?!(IGZCDG)(:XZ%US
MUM2?BRI GG0/L/<$N(^X,&J,JWW69]HI6<>IYW):>>+OK(^"P_X@<$Q1=DZ$
MG-5MY\K_%-LA;/:4\XQBW[5/'J7!O,MPT\-NA=4,HZG =\?' ]OCBEGT!\'C
M^;*^,!S]I'?4@!OZ';*@>!8SHG&.(Q@0,>(X4!(-L*A >.GM)!R^MC8.@!F7
M,Y\MW0N[O-_F*,\NZNH^??(\"S1#7+F*CDAJ$C$N)2)C3%XX$[,X;97XUN(X
MU\^XBCE)PA=V_\>FZ#JHCNO-YK*Z2Y'://(@,FY\'_%0#()]7T#AEO#,<\XH
MU3%.2RR>-#L.A!G7,*>+^<(T?*C+(A1=4:U_PP"G*5R9.\&%1F:)$0(P^$V1
M6,5P,<MHLE0Z)X*:A,)CF^,XF'&-<J*,+PS!60,]P8"![; _UV_M-N\2]B/'
M<6=,*DEH2CBQ21N(B0Z'PBU&,\P9::;M<GW?]C@H9ERGW)&L\X+CI&TOH?EZ
M++CV4?!1$>@+\)(I3:S5FL0$"1\!JK6%72+RJ ?C0)EQX7*G$K_T@@+A$A?%
M&\;]>=&5D$M,BY.TCD!F412 1+P&103+!'?:.P83EY-O+([#8<:ERDD2OK#[
MSQO7OZ?VX6;CZS+G,FEE-"?!6N168VSLDG&$6B/! DTZ8Y-\_\#<.,?/N!SY
M?/%F\M"_N0X7KEK#L)6O1:9P(4M$<X69D+&2.,LD8=K*F )32D]+*Y^R.HZ!
M&5<=)TLYBVKCFPTT:T3YWTU]U5W@XK9UU4W.+29$C$;B!,Y>TBM*K,14F4?E
M7>:3E6):?>EOC(][<6KV]<;IPLZ#CVN<ZZJVZ/6_?14L#TP&H9,@4<:L?R%0
M$HMA#2H$@F-<#!#<+N!X9'D<&3,N1.Y$TEE@<8QZ-:X\P<CW^E>XR3/.(=.8
M(2'@C,C ,.[%Q8]$8%PK%2Q5N]B?^,;L."!F7)Z<+N8+TW"$:5#L4Z&WI5OG
M&8LI9<(08;@FTE%-7!0<J5;:.6EQ8--VMQ^8&^?]&=<DGR_>SKS^>O5(O%,\
M</CJ[D3_I___B,-7_P502P$"% ,4    " #7@&I4EQ^(O(@9  "!.@$ '@
M            @ $     97AH:6)I=#DY,5]Q-#(P,C%E87)N:6YG<W(N:'1M
M4$L! A0#%     @ UX!J5!,:.:"R%   $(D  !$              ( !Q!D
M &YP8V4M,C R,C S,3 N:'1M4$L! A0#%     @ UX!J5.3R;1EK @  90<
M !$              ( !I2X  &YP8V4M,C R,C S,3 N>'-D4$L! A0#%
M  @ UX!J5.$;_C:M"@  _V   !4              ( !/S$  &YP8V4M,C R
M,C S,3!?;&%B+GAM;%!+ 0(4 Q0    ( -> :E2JR*D-X@8  .TR   5
M          "  1\\  !N<&-E+3(P,C(P,S$P7W!R92YX;6Q02P4&      4
,!0!0 0  -$,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
